B
Bull
Bull · 25%XAGE
$4.54
Szenariopreis
$2.320
-0.356 (-15.33%)Zum Schluss
Loading chart…
- High
- 2.799
- Open
- 2.720
- VWAP
- 2.47
- Vol
- 249.03K
- Mkt Cap
- —
- Low
- 2.280
- Amount
- 614.23K
- EV/EBITDA, TTM
- 0.00
Longevity Health Holdings, Inc. is focused on longevity and healthy aging, encompassing the latest scientific advances in regenerative bio-aesthetics. The Company has two cosmetic product lines, Carmell Secretomeand and Elevai Exosomes, that support skin and hair health. All of its cosmetic skincare and haircare products are tailored to meet the demanding technical requirements of professional care providers and discerning retail consumers. The Carmell Secretome consists of a potent cocktail of growth factors, proteins, and peptides extracted from allogeneic human platelets. The Carmell Secretome product portfolio and pipeline includes Face and Neck Collection (Retail), ProSynergy Collection (Doctors/Medspas), and others. The Elevai Exosomes are nano-sized extracellular vesicles containing growth factors, cytokines, peptides, and other small molecules involved in the body’s natural healing process. The Elevai Exosomes skincare products include Elevai Empower and Elevai Enfinity.
Bewertungskennzahlen
The current forward P/E ratio for Longevity Health Holdings Inc (XAGE) is 0.00, compared to its 5-year average forward P/E of 0.00.
Alphio AI Price Scenarios for XAGE
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Event-Zeitleiste
News
7.008-17NewsfilterLongevity Health Settles Litigation, Enhancing Capital Access
3.501-06BenzingaCoinbase CEO Armstrong Invests in NewLimit, Secures $45 Million Funding
7.007-21PRnewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS, ZIMV, XAGE on Behalf of Shareholders
7.007-18PRnewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ONCO, WAT, XAGE on Behalf of Shareholders
8.507-17Globenewswire$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Longevity Health Holdings, Inc. (NASDAQ: XAGE)
XAGE FAQ — answered by Alphio AI
Longevity Health Holdings, Inc. is focused on longevity and healthy aging, encompassing the latest scientific advances in regenerative bio-aesthetics. The Company has two cosmetic product lines, Carmell Secretomeand and Elevai Exosomes, that support skin and hair health. All of its cosmetic skincare and haircare products are tailored to meet the demanding technical requirements of professional care providers and discerning retail consumers. The Carmell Secretome consists of a potent cocktail of growth factors, proteins, and peptides extracted from allogeneic human platelets. The Carmell Secretome product portfolio and pipeline includes Face and Neck Collection (Retail), ProSynergy Collection (Doctors/Medspas), and others. The Elevai Exosomes are nano-sized extracellular vesicles containing growth factors, cytokines, peptides, and other small molecules involved in the body’s natural healing process. The Elevai Exosomes skincare products include Elevai Empower and Elevai Enfinity. It operates in the Healthcare sector.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.